| 摘要 |
The present invention relates to pharmaceutical formulations, in particular novel pharmaceutical formulations in which the active ingredient comprises human antibodies to human interleukin I beta (IL- 1ß), in particular ACZ885 antibody, pharmaceutical formulations which are stable and aggregate-free upon storage and delivery.
|
